Professor David Price
Chair of Primary Care Respiratory Med
- 51cg
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 25 of 97 Results 241 to 250 of 964
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
AMCP Nexus 2022Contributions to Conferences: AbstractsClinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
CHEST 2022, pp. A28-A32Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical Review: The suggested management pathway for urticaria in primary care
Clinical and Translational Allergy, vol. 12, no. 10, e12195Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
CHEST Annual Meeting, pp. A23-A27Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort
npj Primary Care Respiratory Medicine, vol. 32, 37Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Oral corticosteroids in asthma and beyond: moving forward
European Respiratory Journal, vol. 60, no. 3, 2200776Contributions to Journals: Editorials- [ONLINE] DOI:
- [OPEN ACCESS]
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187—2200Contributions to Journals: Articles- [ONLINE] DOI:
- [OPEN ACCESS]
Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study
European Respiratory Society (ERS) International Congress., pp. 2374Contributions to Conferences: Abstracts- [ONLINE]
- [OPEN ACCESS]
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
European Respiratory Society (ERS) International Congress., 4420Contributions to Journals: Abstracts- [ONLINE] DOI: